Gregory Gene Freitag
CIK 1492710 · General Counsel · last filed 2026-03-03
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$12.08M
Companies
4
Total Filings
68
Lifetime Open-Market Net
-$4.05M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| PDSB | Director | 61,213 | $0.69 | $42.3K | $75.0K | 10 | 2026-03-03 |
| ZyVersa Therapeutics, Inc. (ZVSA) Delisted | Director | — | $0.20 | — | $0 | 2 | 2025-07-15 |
| AXGN | Director | 283,498 | $42.47 | $12.04M | -$4.12M | 43 | 2024-06-06 |
| PRESSURE BIOSCIENCES INC (PBIO) Delisted | Director | 1,422 | — | — | $0 | 3 | 2011-10-07 |
Recent Filings · Page 5 of 7
68 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-07-01 | PDSB | Grant (A) | — | $0 | EDGAR |
| 2019-02-19 | AXGN | Grant (A) | +3,377 | $59.3K | EDGAR |
| 2018-12-31 | AXGN | Grant (A) | — | $0 | EDGAR |
| 2018-12-04 | AXGN | Sell (S) | −45,000 | -$1.49M | EDGAR |
| 2018-11-15 | AXGN | Sell (S) | −20,000 | -$645.0K | EDGAR |
| 2018-03-23 | AXGN | Mixed | +28,104 | $14 | EDGAR |
| 2018-03-05 | AXGN | Mixed | +33,095 | $15 | EDGAR |
| 2017-12-20 | AXGN | Grant (A) | — | $0 | EDGAR |
| 2017-09-27 | AXGN | Mixed | +8,550 | -$5 | EDGAR |
| 2017-08-29 | AXGN | Mixed | +19,215 | -$0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.